Literature DB >> 29844520

Generation and validation of homozygous fluorescent knock-in cells using CRISPR-Cas9 genome editing.

Birgit Koch1, Bianca Nijmeijer1, Moritz Kueblbeck1, Yin Cai1, Nike Walther1, Jan Ellenberg1.   

Abstract

Gene tagging with fluorescent proteins is essential for investigations of the dynamic properties of cellular proteins. CRISPR-Cas9 technology is a powerful tool for inserting fluorescent markers into all alleles of the gene of interest (GOI) and allows functionality and physiological expression of the fusion protein. It is essential to evaluate such genome-edited cell lines carefully in order to preclude off-target effects caused by (i) incorrect insertion of the fluorescent protein, (ii) perturbation of the fusion protein by the fluorescent proteins or (iii) nonspecific genomic DNA damage by CRISPR-Cas9. In this protocol, we provide a step-by-step description of our systematic pipeline to generate and validate homozygous fluorescent knock-in cell lines.We have used the paired Cas9D10A nickase approach to efficiently insert tags into specific genomic loci via homology-directed repair (HDR) with minimal off-target effects. It is time-consuming and costly to perform whole-genome sequencing of each cell clone to check for spontaneous genetic variations occurring in mammalian cell lines. Therefore, we have developed an efficient validation pipeline of the generated cell lines consisting of junction PCR, Southern blotting analysis, Sanger sequencing, microscopy, western blotting analysis and live-cell imaging for cell-cycle dynamics. This protocol takes between 6 and 9 weeks. With this protocol, up to 70% of the targeted genes can be tagged homozygously with fluorescent proteins, thus resulting in physiological levels and phenotypically functional expression of the fusion proteins.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29844520      PMCID: PMC6556379          DOI: 10.1038/nprot.2018.042

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  45 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 2.  High-throughput fluorescence microscopy for systems biology.

Authors:  Rainer Pepperkok; Jan Ellenberg
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07-19       Impact factor: 94.444

3.  Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects.

Authors:  Bin Shen; Wensheng Zhang; Jun Zhang; Jiankui Zhou; Jianying Wang; Li Chen; Lu Wang; Alex Hodgkins; Vivek Iyer; Xingxu Huang; William C Skarnes
Journal:  Nat Methods       Date:  2014-03-02       Impact factor: 28.547

4.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

5.  Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells.

Authors:  Van Trung Chu; Timm Weber; Benedikt Wefers; Wolfgang Wurst; Sandrine Sander; Klaus Rajewsky; Ralf Kühn
Journal:  Nat Biotechnol       Date:  2015-03-24       Impact factor: 54.908

6.  Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.

Authors:  Dominik Paquet; Dylan Kwart; Antonia Chen; Andrew Sproul; Samson Jacob; Shaun Teo; Kimberly Moore Olsen; Andrew Gregg; Scott Noggle; Marc Tessier-Lavigne
Journal:  Nature       Date:  2016-04-27       Impact factor: 49.962

7.  Increased gene targeting in Ku70 and Xrcc4 transiently deficient human somatic cells.

Authors:  Luciana R Bertolini; Marcelo Bertolini; Elizabeth A Maga; Knut R Madden; James D Murray
Journal:  Mol Biotechnol       Date:  2008-08-30       Impact factor: 2.695

8.  Comparative assessment of fluorescent transgene methods for quantitative imaging in human cells.

Authors:  Robert Mahen; Birgit Koch; Malte Wachsmuth; Antonio Z Politi; Alexis Perez-Gonzalez; Julia Mergenthaler; Yin Cai; Jan Ellenberg
Journal:  Mol Biol Cell       Date:  2014-09-17       Impact factor: 4.138

9.  Characterization of the interplay between DNA repair and CRISPR/Cas9-induced DNA lesions at an endogenous locus.

Authors:  Anne Bothmer; Tanushree Phadke; Luis A Barrera; Carrie M Margulies; Christina S Lee; Frank Buquicchio; Sean Moss; Hayat S Abdulkerim; William Selleck; Hariharan Jayaram; Vic E Myer; Cecilia Cotta-Ramusino
Journal:  Nat Commun       Date:  2017-01-09       Impact factor: 14.919

10.  Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization.

Authors:  Brock Roberts; Amanda Haupt; Andrew Tucker; Tanya Grancharova; Joy Arakaki; Margaret A Fuqua; Angelique Nelson; Caroline Hookway; Susan A Ludmann; Irina A Mueller; Ruian Yang; Rick Horwitz; Susanne M Rafelski; Ruwanthi N Gunawardane
Journal:  Mol Biol Cell       Date:  2017-08-16       Impact factor: 4.138

View more
  32 in total

1.  Topologically associating domains and chromatin loops depend on cohesin and are regulated by CTCF, WAPL, and PDS5 proteins.

Authors:  Gordana Wutz; Csilla Várnai; Kota Nagasaka; David A Cisneros; Roman R Stocsits; Wen Tang; Stefan Schoenfelder; Gregor Jessberger; Matthias Muhar; M Julius Hossain; Nike Walther; Birgit Koch; Moritz Kueblbeck; Jan Ellenberg; Johannes Zuber; Peter Fraser; Jan-Michael Peters
Journal:  EMBO J       Date:  2017-12-07       Impact factor: 11.598

2.  Chemogenetic Control of Nanobodies.

Authors:  Helen Farrants; Miroslaw Tarnawski; Thorsten G Müller; Shotaro Otsuka; Julien Hiblot; Birgit Koch; Moritz Kueblbeck; Hans-Georg Kräusslich; Jan Ellenberg; Kai Johnsson
Journal:  Nat Methods       Date:  2020-02-17       Impact factor: 28.547

Review 3.  Developments and Applications of Functional Protein Microarrays.

Authors:  Guan-Da Syu; Jessica Dunn; Heng Zhu
Journal:  Mol Cell Proteomics       Date:  2020-04-17       Impact factor: 5.911

4.  A high-efficiency and versatile CRISPR/Cas9-mediated HDR-based biallelic editing system.

Authors:  Xinyi Li; Bing Sun; Hongrun Qian; Jinrong Ma; Magdalena Paolino; Zhiying Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2022-02-15       Impact factor: 3.066

5.  Construction of TSC2 knockout cell line using CRISPR/Cas9 system and demonstration of its effects on NIH-3T3 cells.

Authors:  Xu Wang; Yang Zhao; Zhan Wang; Zhangcheng Liao; Yushi Zhang
Journal:  Cell Biochem Biophys       Date:  2022-10-01       Impact factor: 2.989

Review 6.  The Cardiac Sarcomere and Cell Cycle.

Authors:  Anthony M Pettinato; Feria A Ladha; J Travis Hinson
Journal:  Curr Cardiol Rep       Date:  2022-04-05       Impact factor: 3.955

7.  Qualifying antibodies for image-based immune profiling and multiplexed tissue imaging.

Authors:  Ziming Du; Jia-Ren Lin; Rumana Rashid; Zoltan Maliga; Shu Wang; Jon C Aster; Benjamin Izar; Peter K Sorger; Sandro Santagata
Journal:  Nat Protoc       Date:  2019-09-18       Impact factor: 13.491

8.  Direct Visualization of Single Nuclear Pore Complex Proteins Using Genetically-Encoded Probes for DNA-PAINT.

Authors:  Thomas Schlichthaerle; Maximilian T Strauss; Florian Schueder; Alexander Auer; Bianca Nijmeijer; Moritz Kueblbeck; Vilma Jimenez Sabinina; Jervis V Thevathasan; Jonas Ries; Jan Ellenberg; Ralf Jungmann
Journal:  Angew Chem Int Ed Engl       Date:  2019-08-21       Impact factor: 15.336

9.  Equilibrium between nascent and parental MCM proteins protects replicating genomes.

Authors:  Hana Sedlackova; Maj-Britt Rask; Rajat Gupta; Chunaram Choudhary; Kumar Somyajit; Jiri Lukas
Journal:  Nature       Date:  2020-10-21       Impact factor: 49.962

10.  A quantitative map of human Condensins provides new insights into mitotic chromosome architecture.

Authors:  Nike Walther; M Julius Hossain; Antonio Z Politi; Birgit Koch; Moritz Kueblbeck; Øyvind Ødegård-Fougner; Marko Lampe; Jan Ellenberg
Journal:  J Cell Biol       Date:  2018-04-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.